Fundraising FoxSalphadtx
4 known investors
Find your way into Salphadtx
Sign up to see every warm intro you have to Salphadtx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Salphadtx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
S-Alpha Therapeutics is a Seoul-based digital therapeutics company developing software-based treatment applications.
Also known as S-Alpha Therapeutics
Investors · 4
Company profile
researched Aug 2026S-Alpha Therapeutics (operating at salphadtx.com) is a digital health and digital therapeutics company headquartered in the Seocho district of Seoul, South Korea. It develops a software platform intended to deliver therapeutic interventions, manage user workflows, and collect clinical and usage data for outcomes assessment. The company is listed among life sciences organizations associated with MTEC and is categorized under apps, health care, information technology and therapeutics.
Alongside its software platform, the company offers services spanning end-to-end development of digital therapeutic applications (UX design, backend services and deployment), clinical study support for digital interventions (protocol development, study execution and data management), and regulatory and commercialization advising for software medical products. Stated expertise areas include digital therapeutics, clinical trial management for software interventions, regulatory compliance for digital medical products, behavioral intervention and engagement design, healthcare app software development and QA, and real-world evidence and outcomes analytics.
Business model
The company combines a digital therapeutics software platform with fee-based services, including development of digital therapeutic applications, clinical study support, and regulatory and commercialization advising for digital health products.
▸Full profile — technology, go-to-market, geography
Technology
The company's technology base covers mobile application development, cloud-based analytics, AI/ML-driven user analytics, clinical data capture platforms, digital intervention workflow engines, telehealth integration, secure data storage and privacy controls, and user experience design for health applications. It holds granted US patents covering an antiviral digital device (US-11998742-B1), a digital apparatus and application for treating mild cognitive impairment and dementia (US-11903721-B1), and a digital apparatus and application for treating myopia (US-11189192-B2).
Go-to-market
Organizations developing or evaluating software-based medical products, alongside patients treated through digital therapeutic applications in areas such as mild cognitive impairment and dementia, myopia, and antiviral indications.
Geography
Headquartered in Seocho, Seoul, South Korea.
Compiled by commissioned research from 2 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
▸Research sources · 2
primary sources listed
- S-Alpha Therapeutics | MTECmtec-sc.org · web
2 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Salphadtx do?
- S-Alpha Therapeutics is a Seoul-based digital therapeutics company developing software-based treatment applications.
- Who are Salphadtx's investors?
- Salphadtx's investors include Aju IB Investment, Kiwoom Investment, LB Investment, Korea Investment Partners.